| 000 | 01857 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250516073447.0 | ||
| 264 | 0 | _c20120327 | |
| 008 | 201203s 0 0 eng d | ||
| 022 | _a1938-2375 | ||
| 024 | 7 |
_a10.3928/15428877-20111129-01 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCanton, Virgilio Morales | |
| 245 | 0 | 0 |
_a24-Gy low-voltage x-ray irradiation with ranibizumab therapy for neovascular AMD: 6-month safety and functional outcomes. _h[electronic resource] |
| 260 |
_bOphthalmic surgery, lasers & imaging : the official journal of the International Society for Imaging in the Eye _c |
||
| 300 |
_a20-4 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial, Phase I; Journal Article | ||
| 650 | 0 | 4 |
_aAngiogenesis Inhibitors _xadverse effects |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal, Humanized _xadverse effects |
| 650 | 0 | 4 | _aCombined Modality Therapy |
| 650 | 0 | 4 | _aFluorescein Angiography |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIntravitreal Injections |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aRadiotherapy Dosage |
| 650 | 0 | 4 | _aRanibizumab |
| 650 | 0 | 4 | _aTomography, Optical Coherence |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aVisual Acuity _xphysiology |
| 650 | 0 | 4 |
_aWet Macular Degeneration _xdrug therapy |
| 700 | 1 | _aQuiroz-Mercado, Hugo | |
| 700 | 1 | _aVelez-Montoya, Raul | |
| 700 | 1 | _aLopez-Miranda, Miriam J | |
| 700 | 1 | _aMoshfeghi, Andrew A | |
| 700 | 1 | _aShusterman, Eugene M | |
| 700 | 1 | _aKaiser, Peter K | |
| 700 | 1 | _aSanislo, Steven R | |
| 700 | 1 | _aGertner, Michael | |
| 700 | 1 | _aMoshfeghi, Darius M | |
| 773 | 0 |
_tOphthalmic surgery, lasers & imaging : the official journal of the International Society for Imaging in the Eye _gvol. 43 _gno. 1 _gp. 20-4 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.3928/15428877-20111129-01 _zAvailable from publisher's website |
| 999 |
_c21467385 _d21467385 |
||